Antares Pharma Inc.

NASDAQ: ATRS · Real-Time Price · USD
5.59
0.01 (0.18%)
At close: Apr 24, 2025, 3:47 PM

Antares Pharma Revenue

Antares Pharma reported an annual revenue of $183.98M, reflecting a 22.98% growth. For the quarter ending March 31, 2022, Antares Pharma generated $41.56M in revenue.
Revenue (ttm)
183.98M
Revenue Growth
22.98%
Price / Sales Ratio
3.3
Revenue / Employee
915.33K
Employees
201
Market Cap
0

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2021 183.98M +22.98%
Dec 31, 2020 149.6M +20.78%
Dec 31, 2019 123.86M +94.90%
Dec 31, 2018 63.55M +16.58%
Dec 31, 2017 54.52M +4.39%
Dec 31, 2016 52.22M +14.38%
Dec 31, 2015 45.66M +72.28%
Dec 31, 2014 26.5M +28.53%
Dec 31, 2013 20.62M -8.67%
Dec 31, 2012 22.58M +37.17%
Dec 31, 2011 16.46M +28.39%
Dec 31, 2010 12.82M +54.24%
Dec 31, 2009 8.31M +46.82%
Dec 31, 2008 5.66M -27.95%
Dec 31, 2007 7.86M +84.07%
Dec 31, 2006 4.27M +91.86%
Dec 31, 2005 2.22M -18.98%
Dec 31, 2004 2.75M -27.49%
Dec 31, 2003 3.79M -5.23%
Dec 31, 2002 4M +14.21%
Dec 31, 2001 3.5M +75.52%
Dec 31, 2000 1.99M -42.75%
Dec 31, 1999 3.48M +26.57%
Dec 31, 1998 2.75M -25.99%
Dec 31, 1997 3.72M +0.68%
Dec 31, 1996 3.69M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.